HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-7-cyano-2,3,4,5-tetrahydro-4-(phenylacetyl)-3-(phenylmethyl)-1H-1,4-benzodiazepine → HCID 178504913, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-7-cyano-2,3,4,5-tetrahydro-4-(phenylacetyl)-3-(phenylmethyl)-1H-1,4-benzodiazepine | HCID 53636257 | — |
| Reactant | (R)-7-cyano-2,3,4,5-tetrahydro-1-[(((1,1-dimethylethoxy)-carbonyl)-1H-imidazol-4-yl)methyl]-4-(methylsulfonyl)-3-(phenylmethyl)-1H-1,4-benzodiazepine | HCID 69841490 | — |
| Reactant | 2-Stannyl pyrimidine | HCID 87150656 | — |
| Reactant | HCID 178478619 | HCID 178478619 | — |
| Product | HCID 178504913 | HCID 178504913 | — |
Reaction Steps
Example 332 was prepared as a yellow solid from Compound A of Example 231 and 2-stannylpyrimidine as described for Compound B of Example 231 and Compound C of Example 231. MS (M+H)+ 475.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06011029 |
| Source dataset | uspto-grants-2000_01 |
| ORD ID | ord-7e483e887e9045a9a505db4f30b54f34 |
| Source note | uspto-grants-2000_01 |